TG Therapeutics, Inc.

NasdaqCM:TGTX Stock Report

Mkt Cap: US$2.0b

TG Therapeutics Financial Health

How is TG Therapeutics's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: TGTX's short term assets ($182.9M) exceed its short term liabilities ($36.4M).

Long Term Liabilities: TGTX's short term assets ($182.9M) exceed its long term liabilities ($81.0M).

Debt to Equity History and Analysis

Debt Level: TGTX has more cash than its total debt.

Reducing Debt: TGTX's debt to equity ratio has increased from 0.2% to 69.8% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TGTX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if TGTX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.

Discover healthy companies